Ryanodex 250 MG vials
Ended Awarded Last action
- Contract number
- SPE2D325F473E
- Awardee
-
Eagle Pharmaceuticals, Inc. UEI VRQKPMHD3CK7
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $7,057
Award facts
- Contract value 100% obligated
- $7,056.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Westwood, NJ 07677, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $7,056.88 to Eagle Pharmaceuticals, Inc. for the supply of Ryanodex 250 mg vials. This award, issued on September 30, 2025, represents a firm fixed-price delivery order with an ultimate completion date of October 3, 2025 and carries no set-aside designation. The contract will be performed at Eagle Pharmaceuticals' manufacturing facility in Westwood, New Jersey. Ryanodex is a critical injectable medication used to treat and prevent malignant hyperthermia, a rare but life-threatening pharmacogenetic disorder that can occur during anesthesia.
This delivery order is issued under Eagle Pharmaceuticals' existing Federal Supply Schedule contract with the Department of Veterans Affairs Veterans Integrated Service Network 12, a multiple-award vehicle valued at $30.9 million and effective through January 31, 2029. Eagle Pharmaceuticals serves as the established prime contractor on this procurement mechanism, which enables the Defense Logistics Agency Troop Support Medical and VA facilities across New Jersey, Pennsylvania, and Delaware to procure specialized injectable pharmaceuticals on an as-needed basis. The company's consistent selection as a federal supplier reflects its established role as a reliable vendor for critical pharmaceutical products supporting military readiness and veterans' healthcare operations.
Quick answers
Who was awarded contract SPE2D325F473E?
SPE2D325F473E was awarded to Eagle Pharmaceuticals, Inc. by Medical Supply Chain (Troop Support) on September 30, 2025.
How much is contract SPE2D325F473E worth?
The government has obligated $7,057 on SPE2D325F473E.
Is contract SPE2D325F473E an order under another contract?
Yes. SPE2D325F473E is a delivery order under SPE2D018D0006, an indefinite delivery contract.
Was contract SPE2D325F473E competed?
The extent of competition for SPE2D325F473E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award